French Valproate Study Finds High Risk Of Birth Defects
PARIS — Two French agencies on April 20 announced the results of a study showing a high birth defect effect from valproate, commonly sold as the antiepileptic drug Depakote in the...To view the full article, register now.
Already a subscriber? Click here to view full article